Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a biomarker that can be used to assess the risk for cardiovascular disease and events. In addition to being a useful marker of a risk factor, several studies suggest that Lp-PLA2 has a pathophysiologic role in the atherosclerotic disease process. In this article we review this aspect and its therapeutic implications.
|Original language||English (US)|
|Number of pages||6|
|Journal||Current atherosclerosis reports|
|State||Published - Jun 2008|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine